Tuberculosis (TB) in prisons is a major health problem in countries of high and intermediate TB endemicity such as Brazil. For operational reasons, TB control strategies in prisons cannot be compared through population based intervention studies.
A mathematical model is proposed to simulate the TB dynamics in prison and evaluate the potential impact on active TB prevalence of several intervention strategies. The TB dynamics with the ongoing program was simulated over a 10 year period in a Rio de Janeiro prison (TB prevalence 4.6 %). Then, a simulation of the DOTS strategy reaching the objective of 70 % of bacteriologically-positive cases detected and 85 % of detected cases cured was performed; this strategy reduced only to 2.8% the average predicted TB prevalence after 5 years. Adding TB detection at entry point to DOTS strategy had no major effect on the predicted active TB prevalence. But, adding further a yearly X-ray mass screening of inmates reduced the predicted active TB prevalence below 1%. Furthermore, according to this model, after applying this strategy during 2 years (three annual screenings), the TB burden would be reduced and the active TB prevalence could be kept at a low level by associating X-ray screening at entry point and DOTS.
Citation: Legrand J, Sanchez A, Le Pont F, Camacho L, Larouze B (2008) Modeling the Impact of Tuberculosis Control Strategies in Highly Endemic Overcrowded Prisons. PLoS ONE 3(5): e2100. doi:10.1371/journal.pone.0002100
Editor: Cesar Augusto Ugarte-Gil, Instituto de Medicina Tropical Alexander Von Humboldt, Peru
Received: September 20, 2007; Accepted: March 6, 2008; Published: May 7, 2008
Copyright: © 2008 Legrand et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partially supported by the joined program Institut National de la Santé et de la Recherche Médicale, France/Fondation Oswaldo Cruz, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
All over the world, tuberculosis (TB) is a public health problem in prisons due to the fact that many inmates come from communities at high risk of TB, to their living conditions in prisons and to the insufficiencies of prisons' health services . This problem is particularly critical in countries of high and intermediate TB endemicity such as Brazil. In Rio de Janeiro (RJ) state prisons, the 2005 annual TB incidence rate was as high as 3 500/100 000 , 35 times higher than in the general population of the state . Recent X-ray surveys performed in three RJ prisons found prevalence rates of active TB ranging from 4.6 to 8.6% , .
In addition to the universal World Health Organization (WHO) Directly Observed Treatment Short-course (DOTS) strategy , several measures have been proposed by WHO and the Red Cross to control TB in the prisons  including mass screening of prisoners based on symptoms  and the systematic detection of TB at entry point, commonly used in high income countries , . However, the respective efficacy of these measures and of their combinations remains to be demonstrated, particularly in countries of high and intermediate TB endemicity . But, in the context of prisons, comparative intervention studies to measure the efficacy of control strategies would be unfeasible and would raise ethical questions. Therefore, in order to explore the impact of several TB control strategies on the prevalence of active TB, we developed a mathematical model of TB dynamics in prisons. In the present study, parameter values were drawn from the medical literature and from epidemiological studies previously conducted in one of the RJ prison units .
Materials and Methods
Based on previously published works –, we developed a stochastic compartmental model where the population is distributed into 10 groups (see figure 1). This model allows the simulation of infection and re-infection, detection and treatment of cases, treatment failure, death from tuberculosis, self cure and incarceration of new prisoners. Susceptible individuals (S) can be infected by infectious TB cases (see figure 1, transitions 1–2). Infected cases can be either fast (E) or slow (L) progressors, the rate of progression from latency to active TB being greater for fast progressors (transitions 3–10). Active TB cases are divided into four groups according to whether they will be detected and treated thanks to passive detection (D) or not (T) and whether they are infectious (subscript i) or not (subscript n). However, non infectious cases can become infectious (transitions 11–13). After an average duration of 1/k years, cases in D states are detected and move to the recovered compartment (R) if the treatment is successful (transitions 14–15). Otherwise, they move to the treatment failure compartment (Yi and Yn, transitions 16–17) before re-entering compartments T or D (transitions 18–21). Undetected TB cases (Ti and Tn) can be self-cured (transitions 22–23). Recovered individuals (R) can relapse (transitions 24–27). Latent slow progressors (L) and cured individuals (R) can be re-infected by infectious cases (transitions 28–29). The rates of entries in compartments depend on the prevalence of TB infection and active TB at entry point and on the simulated TB control strategy. The rate of discharge in each compartment is proportional to the size of this compartment. Parameter definitions are given in table 1 and detailed transition rates are given in table 2. We considered that smear-positive and smear-negative/culture positive cases are infectious and that smear negative/culture negative TB cases are not.
Each box represents a compartment: Susceptible individuals (S), latent fast progressors (E), latent slow progressors (L), cured individuals (R), infectious/non-infectious cases who will be detected and treated (Di/Dn), infectious/non-infectious cases who will not be detected and treated (Ti/Tn), infectious/non-infectious treated cases with treatment failure (Yi/Yn). Red boxes represent a disease-infectious state, pink boxes represent a disease-non infectious state and grey boxes represent infected individuals without disease. Entries and discharges in and out of the prison are not represented on this figure.
Simulations of the model were performed using the Gillespie's first reaction method . A transition rate, λi, depending only on the present state of the population, is allocated to each transition between two compartments. At each iteration of the algorithm, a time τi is drawn from an exponential distribution with parameter λi for each transition. The next transition µ is the transition that has the minimum time to occurrence (τµ). Then, counts in each compartment are updated accordingly.
Background and source of data
The 35 RJ State prisons hold nearly 23 000 inmates. In the present study, we investigated the TB dynamics in one of the RJ prisons (around 1000 inmates) where the prevalence of active TB is 4.6% . As in most of RJ prisons, cells are overcrowded (median: 33 inmates/cell) and poorly ventilated. The inmates are sentenced for at least 8 years but, due to movements of inmates among prisons and to incarceration/freeing, the annual turnover of inmates is around one third. The TB control is based on the DOTS strategy which includes case detection through quality assured-bacteriology and standardized treatment with supervision and patient support . There is no TB detection at entry in prison and no mass screening in the prison. Prevalence of active TB and prevalence of TB infection in prison and at entry point were inferred from surveys carried out in RJ prison units. The values of other parameters were obtained from the literature (see table 1).
Simulation of TB control strategies
We first simulated the evolution of active TB prevalence in the prison over a 10 year period if the current TB control strategy remains unchanged. For simulating this current scenario, we considered that, among prisoners entering the prison, the prevalence of latent TB infection (defined as a positive tuberculin skin test after excluding active TB cases) is 47.0% and that the prevalence of active TB (evaluated through X-ray screening and bacteriological diagnostic tests) is 1.5% (unpublished data). Among inmates, we considered a prevalence of latent TB infection at 60.6% and a prevalence of active TB at 4.6% . Furthermore, in line with the data from the prison TB surveillance system and prevalence surveys, we assumed that 43% of new infectious cases are detected, that 34% of new non infectious cases are detected and that 65% of treated cases are cured. The transmission rate was calibrated in such a way that the average predicted prevalence of active TB remains roughly stable over this 10 year period. The calibration of the model was done by determining the size of each compartment at time t = 0 and the value of the transmission rate leading to the equilibrium of the deterministic version of the model and fulfilling the constraints on the values of the prevalence of infection and of disease in the prison and at the entry in prison.
Then, we explored the potential effect on active TB prevalence of several simulated strategies (S1 to S5) based on the following control methods, considered alone or associated, as shown in table 3:
- DOTS strategy reaching the WHO target : to detect 70% of new bacteriologically-positive cases and to cure 85% of detected cases
- Systematic detection of TB at entry point of symptomatic (cough>3 weeks) smear-positive cases
- Systematic detection of TB at entry point using chest X-ray
- Annual X-ray mass screening of inmates.
Considering the cost and the operational complexity of annual X-ray mass screening included in strategies 4 and 5 described in table 3, we simulated strategies (S6 and S7) including a first 2 years phase of the DOTS associated with X-ray detection at entry and annual X-ray mass screening (3 X-ray mass screenings) followed by a second phase limited to DOTS plus X-ray detection at entry (S6) or to DOTS alone (S7).
To implement the DOTS strategy, we modified the values of the proportions of new cases detected (f1, f2) and the value of the proportion of detected cases cured by treatment (g) as shown in table 1. We considered that smear-negative/culture-negative cases are not detected.
To simulate the systematic detection of TB at entry point (based on symptoms or chest X-ray), we considered that detected cases would be treated as soon as they are detected and we modified the relative proportion of cases entering compartments T, D, Y and R accordingly. X-ray screenings were simulated by moving cases from compartments T, D, Y to compartments Y and R. We considered that X-ray screening allows the detection of 100% of cases, that all detected cases are treated and that the screening of smear-positive symptomatic cases at entry point allows the detection of 21% of bacteriologically positive cases . Other parameter values are presented in table 1.
For the current scenario and for each simulated strategy, we performed 600 runs of the model and computed the mean and the percentiles 5 and 95 of the active TB prevalence at different dates.
Multivariate uncertainty and sensitivity analyses
Then, to understand how uncertainty on parameters would affect uncertainty on the results obtained for each strategy described in table 3, we performed multivariate uncertainty and sensitivity analyses including all parameters except those defining each strategy (detection and cure rates). We carried out one analysis for the current scenario and one for each of the strategies S1-S7. Using the Latin Hypercube Sampling method (LHS), we generated a sample of set of parameters using distributions of parameter described in table 1 , . The active TB average prevalence on 600 runs was considered as the model output. Hence, for each analysis, we computed the average predicted prevalence of active TB after 10 years with each set of parameters of the Latin Hypercube Sample. The same sample was used for the eight analyses.
Then, in order to quantify the impact of the variation of each parameter on the output of the model, we computed the partial rank correlation coefficients (PRCC) between each parameter and the average predicted prevalence of active TB with each strategy .
Simulations with each strategy
Simulations are performed over a 10 years period for the seven strategies (black lines) and for the current scenario (grey lines). The continuous line represents the mean of the prevalence on 600 simulations and the vertical line extremities represent percentiles 5 and 95.
Assuming that the active TB prevalence would remain stable if the ongoing scenario was applied, we calibrated the transmission rate at 11.10−3. With this scenario, the average number of new cases detected during the first year was 1290 [(P5, P95) = (780, 1860)] per 100 000.
When we simulated the implementation of the DOTS strategy meeting the WHO target (S1), the model predicted a slow decreasing trend of active TB average prevalence from 4.6 to 3.4% (2.4, 4.5) at year 3 and 2.2% (1.3, 3.3) at year 10. Adding to this strategy a systematic TB detection at entry point based on symptoms (S2) had no additional effect. Results were slightly improved when mass screening at entry point was based on X-ray (S3).
Considering the limited and slow decreasing trends observed with S1, S2 and S3 strategies, we simulated strategies associating annual mass X-ray plus DOTS and screening at entry point (S4 and S5). When simulating these strategies, we observed a rapid decrease in active TB average prevalence from 4.6 to 0.7% (0.3, 1.2) at year 3 when the screening at entry point was based on symptoms (S4). Active TB average prevalence was slightly lower when the screening at entry point was based on X-ray (S5). In both instances, at year 10, the active TB average prevalence did not exceed 0.5% and the active TB prevalence exceeded 1% in less than 5% of the 600 runs.
We also simulated strategy 5 during 2 years and, then, limited the intervention to DOTS plus X-ray screening at entry point (S6). After the rapid reduction in active TB prevalence mentioned above, the average predicted active TB prevalence remained below 1% until the 10th year.
When we simulated the same strategy (S6) without screening at entry point after the 2 first years (S7), the average active TB prevalence increased faster to reach 1.7% (0.8, 2.7) at year 10. With this last scenario, more than 90% of the simulated active TB prevalences exceeded 1%.
Multivariate uncertainty and sensitivity analyses
The empiric distributions of parameters in the LHS are represented in figure 3. According to our sensitivity analysis, the uncertainty of our predictions was much lower with S4, S5 and S6 than with other strategies (see figure 4). Indeed, with S1, S2, S3 and S7, the average predicted prevalence of active TB after 10 years could reach 2.5% or more for several of the sets of parameters generated with the LHS method, whereas the average predicted prevalence of active TB with S4, S5 and S6 after 10 years was below 0.7, 0.4 and 1.5% respectively for 95% of these sets of parameters.
Boxplots of the average prevalence after 10 years (%). For each set of parameters of the sample generated by the Latin Hypercube Sampling method and each strategy, we performed 600 runs of the model and computed the average prevalence after 10 years. Each boxplot represents the median, the first and third quartiles (Q1 and Q3), the mean and the maximum and minimum values which are in the range [Q1−1.5 IQR, Q3+1.5 IQR] with IQR equal to the inter-quartile range (Q3-Q1).
The sensitivity analysis showed that, for all strategies, the parameters whose variations had the greatest impact on our predictions at 10 years were the proportion of fast progressors, the death rate of untreated TB, the partial immunity afforded by previous infection, the transmission rate and the rate at which detected cases would be detected (see table 4).
The rate at which slow progressors develop TB had also an important impact on the predicted prevalence of active TB after 10 years for strategies including an annual mass screening during ten years (S4 and S5) and, in a less marked way, for strategies including a mass screening limited to 2 years (S6 and S7). Furthermore, for S5, the average predicted prevalence of active TB was impacted by the rate of relapse.
For all strategies, the transmission rate, the proportion of fast progressors and the rate at which slow progressors develop active TB were positively correlated with the average predicted prevalence of active TB; thus overestimating one of these parameters would lead to underestimate the efficacy of the simulated strategies. On the contrary, for all simulated strategies, the level of partial immunity afforded by previous infection, the death rate of untreated TB and the rate at which TB cases would be detected and treated were negatively correlated with the average predicted prevalence of active TB.
According to the predictions of our model applied to a prison with features similar to other prisons in RJ, the association of the DOTS strategy with annual X-ray mass screenings would allow to obtain a rapid and sustained decline in active TB prevalence. Furthermore, after reducing the TB burden by implementing three annual X-ray mass screenings, the sole association of X-ray screening at entry point and DOTS could be sufficient to maintain a low active TB prevalence level during several years. The better performance of strategies including annual X-ray screening can be explained by the assumption that X-ray screenings allow the rapid diagnosis of all active TB cases, including asymptomatic and not yet infectious cases which are not detected by the DOTS strategy. By this way, the pool of active TB cases decreases drastically although it is then increased by the development of TB among infected individuals, treatment failure, relapse from treatment and by active TB cases entering the prison for strategies which do not include X-ray screening at entry. The limited performance of DOTS on its own in this highly endemic setting can be explained by the fact that it does not decrease rapidly the pool of active TB cases.
We have shown that the uncertainty of our predictions was less important for strategies which included an annual mass screening (S4, S5). For these strategies, the rate at which slow progressors develop TB was one of the parameters whose variations had the greatest impact on the predicted active TB prevalences. Indeed, these strategies would decrease rapidly the prevalence of infectious cases in the prison; as a consequence, the role of exogenous infections in TB transmission would be reduced, and the relative contribution of endogenous reactivation to the incidence of active TB would be larger.
The value of the transmission rate had also an important impact on our predictions. It was calibrated so that, with the current scenario, the active TB prevalence would remain roughly stable over 10 years. The average incidence we predicted was in line with the annual incidences observed during the years prior to our prevalence survey in the prison we investigated . This value of the transmission rate is in the high range of values used in previously published models concerning general populations , , a finding consistent with results of previous studies  showing the strong relationship of overcrowding with TB transmission in a highly endemic prison. However, for various reasons including a greater transmission rate or a larger proportion of recent infections, the active TB prevalence may increase rather than being stable in some prisons. Under this circumstance, all strategies may be less effective. Nonetheless, the performance of strategies including X-ray screening should remain more effective as all active TB cases would be detected each year.
In our multivariate sensitivity analysis, we did not include the sensitivity of X-ray as a screening method, considering it was 100% in agreement with results of previous studies which evaluated at 0.97 (0.90; 1.0) the sensitivity of any chest X-ray abnormality for detecting bacteriologically positive TB cases . If the sensitivity was smaller, our predictions could have overestimated the relative impact of strategies including X-ray screening. Furthermore, in the present study, we limited our simulations of mass screening to X-ray based screening. Indeed, mass screening based on symptoms, commonly used in prevalence surveys , ,  and recommended in prison's TB control program , performed poorly when compared with X-ray based screening , , –.
The need for longitudinal studies concerning the impact of TB screening at entry point has been recently underlined . Using our model, the comparison of predicted active TB prevalence trends observed under strategy 7 versus strategy 6 shows that, in the highly endemic prison we investigated, X-ray screening at entry point would have a greater impact when active TB prevalence is reduced after three annual X-Ray mass screenings. In the case of high active TB prevalence, given the heavy circulation of Mycobacterium tuberculosis (MTB) within the prison, the contribution of infectious TB cases among inmates at entry to this overall MTB circulation is relatively limited, even if the active TB prevalence at entry is high as observed in the prison we studied (1.5%). In our study, we considered that the prevalence of TB infection and active TB among inmates at entry point is constant during the whole ten year study period. The high active TB prevalence at entry point could be decreased in RJ state prisons by reducing the major overcrowding and introducing health care in the police remand where the convicts are incarcerated for periods of time which can last for more than 6 months before they are transferred to prison units. The effect of this strategy could be evaluated by using our model.
Aimed at providing evidences to guide decision makers, the model we propose concerning a Brazilian prison can be applied to other overcrowded institutions with different level of TB prevalence at entry point and inside the institution. Available incidence and prevalence data suggest that a similar TB situation prevails in most RJ state prisons ,  where our strategic conclusions may apply as well as to other highly endemic prisons and institutions worldwide. However, we must keep in mind that an underlying assumption of our model is the homogeneous mixing of the population investigated. Due to overcrowding conditions in collective cells, this assumption is probably appropriate for the prison we studied, but may not be valid for units where the number of inmates per cell and the circulation of inmates are limited, such as high security units.
Given the relatively low level of HIV seroprevalence in our study population (2.1%), we did not take into account in our model the effect of HIV-infection on TB . In many prisons worldwide, the HIV seroprevalence is much higher ,  and HIV infection should be considered given its interactions with TB . Further, the drug resistance was not a major problem in the prison we studied  and in other prisons we subsequently studied in RJ State . Therefore, we did not consider this issue and our model should be modified on the basis of previously published studies , , – when applied to prisons where drug resistance is a major problem.
The predictions based on our model show that the impact of the DOTS strategy alone, even if it reaches the WHO objectives of 70% of bacteriologically positive cases detected and 85% of detected cases cured, is too slow to face the urgent situation of high TB endemicity in the prison we investigated and in similar settings. Indeed, the DOTS strategy should remain the basic tool to control TB in prison but, given its limited impact in the case of high active TB prevalence, active detection, preferentially based on X-ray, should be considered at entry in prison and among inmates already incarcerated.
Several surveys performed in RJ prisons ,  and elsewhere  demonstrated the feasibility of X-ray screening and its excellent acceptance by inmates. Finally, our model may provide the elements for cost-effectiveness analysis of tuberculosis control approaches which need to be explored in further research.
The authors thank Pr John Murray, Pr Donald Enarson, Dr Pierre Chauvin and Dr Veronique Massari for interesting suggestions and Mahinda Siriwardana for editorial revision.
Conceived and designed the experiments: JL AS FL LC BL. Performed the experiments: JL. Analyzed the data: JL AS FL LC BL. Contributed reagents/materials/analysis tools: JL AS FL BL. Wrote the paper: JL AS LC BL.
- 1. Coninx R, Maher D, Reyes H, Grzemska M (2000) Tuberculosis in prisons in countries with high prevalence. Bmj 320: 440–442.
- 2. Secretaria de Estado de Administração Penitenciária do Rio de Janeiro (2006) Relatório Técnico Anual do Programa de Controle de Tuberculose. Rio de Janeiro, Brasil.
- 3. Secretaria de Estado de Saúde do Rio de Janeiro (2006) Relatório Técnico Anual do Programa de Pneumologia Sanitária. Rio de Janeiro, Brasil.
- 4. Sanchez A, Gerhardt G, Natal S, Capone D, Espinola A, et al. (2005) Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int J Tuberc Lung Dis 9: 633–639.
- 5. Sanchez AR, Massari V, Gerhardt G, Barreto AW, Cesconi V, et al. (2007) [Tuberculosis in Rio de Janeiro prisons, Brazil: an urgent public health problem]. Cad Saude Publica 23: 545–552.
- 6. (2001) (2001) Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 5: 213–215.
- 7. Bone A, Aerts A, Grzemska M, Kimerling ME, Kluge H, et al. (2000) Tuberculosis Control in Prisons. A Manual for Programme Managers. World Health organization, International Comitee of the Red Cross.
- 8. Aerts A, Habouzit M, Mschiladze L, Malakmadze N, Sadradze N, et al. (2000) Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis 4: 1104–1110.
- 9. (2006) (2006) Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 55: 1–44.
- 10. Layton MC, Henning KJ, Alexander TA, Gooding AL, Reid C, et al. (1997) Universal radiographic screening for tuberculosis among inmates upon admission to jail. Am J Public Health 87: 1335–1337.
- 11. Kimerling ME, Kluge H (2005) The need for longitudinal screening studies in prison TB control. Int J Tuberc Lung Dis 9: 589.
- 12. Blower SM, McLean AR, Porco TC, Small PM, Hopewell PC, et al. (1995) The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med 1: 815–821.
- 13. Blower SM, Small PM, Hopewell PC (1996) Control strategies for tuberculosis epidemics: new models for old problems. Science 273: 497–500.
- 14. Blower SM, Gerberding JL (1998) Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework. J Mol Med 76: 624–636.
- 15. Dye C, Garnett GP, Sleeman K, Williams BG (1998) Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 352: 1886–1891.
- 16. Porco TC, Blower SM (1998) Quantifying the intrinsic transmission dynamics of tuberculosis. Theor Popul Biol 54: 117–132.
- 17. Dye C, Williams BG (2000) Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci U S A 97: 8180–8185.
- 18. Blower SM, Chou T (2004) Modeling the emergence of the ‘hot zones’: tuberculosis and the amplification dynamics of drug resistance. Nat Med 10: 1111–1116.
- 19. Cohen T, Murray M (2004) Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 10: 1117–1121.
- 20. Sanchez MA, Blower SM (1997) Uncertainty and sensitivity analysis of the basic reproductive rate. Tuberculosis as an example. Am J Epidemiol 145: 1127–1137.
- 21. Vynnycky E, Fine PE (1997) The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 119: 183–201.
- 22. den Boon S, White NW, van Lill SW, Borgdorff MW, Verver S, et al. (2006) An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int J Tuberc Lung Dis 10: 876–882.
- 23. Gillepsie DT (1976) A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions. Journal of Computational Physics 22:
- 24. Blower SM, Hartel D, Dowlatabadi H, Anderson RM, May RM (1991) Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc Lond B Biol Sci 331: 171–187.
- 25. Dye C, Espinal MA (2001) Will tuberculosis become resistant to all antibiotics? Proc Biol Sci 268: 45–52.
- 26. MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NM (1997) Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis 24: 1060–1067.
- 27. Aerts A, Hauer B, Wanlin M, Veen J (2006) Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 10: 1215–1223.
- 28. (2003) (2003) Rapid assessment of tuberculosis in a large prison system–Botswana, 2002. MMWR Morb Mortal Wkly Rep 52: 250–252.
- 29. Jones TF, Schaffner W (2001) Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med 164: 77–81.
- 30. Leung CC, Chan CK, Tam CM, Yew WW, Kam KM, et al. (2005) Chest radiograph screening for tuberculosis in a Hong Kong prison. Int J Tuberc Lung Dis 9: 627–632.
- 31. Fournet N, Sanchez A, Massari V, Penna L, Natal S, et al. (2006) Development and evaluation of tuberculosis screening scores in Brazilian prisons. Public Health 120: 976–983.
- 32. Chaves F, Dronda F, Cave MD, Alonso-Sanz M, Gonzalez-Lopez A, et al. (1997) A longitudinal study of transmission of tuberculosis in a large prison population. Am J Respir Crit Care Med 155: 719–725.
- 33. Nyangulu DS, Harries AD, Kang'ombe C, Yadidi AE, Chokani K, et al. (1997) Tuberculosis in a prison population in Malawi. Lancet 350: 1284–1287.
- 34. Stansell J, Murray J (1994) Pulmonary complications of human immuno-deficiency virus (HIV) infection. In: Murray J, Nadel J, editors. Textbook of Respiratory Medicine 2nd ed. Philadelphia: WB Saunders. pp. 2333–2367.